Literature DB >> 4834081

Levamisole inactive in treatment of four animal tumours.

C W Potter, I Carr, R Jennings, R C Rees, F McGinty, V M Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4834081     DOI： 10.1038/249567a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Augmentation of the in vitro mitogenic response of owl monkey peripheral blood lymphocytes by levamisole and loss of this effect with the development of herpesvirus saimiri-induced lymphoma.

Authors:  R H Neubauer; H Rabin
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  In vitro stimulation of murine lymphoid cell cultures by levamisole.

Authors:  V J Merluzzi; A M Badger; C W Kaiser; S R Cooperband
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

3.  Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.

Authors:  R B Faanes; P Dillon; Y S Choi
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

4.  The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.

Authors:  B Boeryd; A Benktson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

5.  Ineffectiveness of levamisole as adjuvant to surgery with two lines of transplanted rat colonic carcinoma.

Authors:  M S Martin; E Justrabo; F Martin; M F Michel; A Leclerc
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.